Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 2/20 | 0.40 |
| ▸ | GPR119 | Q8TDV5 | 13/20 | 0.38 |
| ▸ | NMT1 | P30419 | 2/20 | 0.38 |
| ▸ | CNR2 | P34972 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | MGLL | Q99685 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10296272 | 0.87 | SMN1; SMN2 (0.43) | FAAHGPR119CNR2KDM4EALDH1A1 | |
| SCHEMBL10296248 | 0.83 | FAAH (0.42) | FAAHGPR119NMT1KDM4EALDH1A1 | |
| SCHEMBL13462415 | 0.82 | GPR119 (0.55) | GPR119NMT1 | |
| SCHEMBL13462347 | 0.79 | SMN1; SMN2 (0.47) | FAAHALDH1A1MGLL | |
| SCHEMBL13462348 | 0.78 | NAMPT (0.46) | FAAHKDM4EALDH1A1MGLL | |
| SCHEMBL10296266 | 0.77 | GPR119 (0.49) | GPR119ALDH1A1 | |
| SCHEMBL1575459 | 0.73 | PTPN2 (0.54) | GPR119 | |
| SCHEMBL1575330 | 0.73 | GPR119 (0.53) | FAAHGPR119KDM4E | |
| SCHEMBL1575460 | 0.72 | PTPN2 (0.65) | GPR119 | |
| SCHEMBL1575684 | 0.71 | GPR119 (0.53) | GPR119 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120172358-A1 | GPCR Agonists | PROSIDION LIMITED (GB) | 2012-07-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120172358-A1 | GPCR Agonists | GPR119, GCGR, GPR27 | FAAH 295/4885GPR119 1/4885NMT1 1642/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.